Caseware UK (AP4) 2025.0.111 2025.0.111 2025-12-312025-12-314The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.truefalseManufacture of medical and dental instruments and supplies2025-01-01false2false 14698419 2025-01-01 2025-12-31 14698419 2024-01-01 2024-12-31 14698419 2025-12-31 14698419 2024-12-31 14698419 c:Director2 2025-01-01 2025-12-31 14698419 d:CurrentFinancialInstruments 2025-12-31 14698419 d:CurrentFinancialInstruments 2024-12-31 14698419 d:Non-currentFinancialInstruments 2025-12-31 14698419 d:Non-currentFinancialInstruments 2024-12-31 14698419 d:CurrentFinancialInstruments d:WithinOneYear 2025-12-31 14698419 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 14698419 d:Non-currentFinancialInstruments d:AfterOneYear 2025-12-31 14698419 d:Non-currentFinancialInstruments d:AfterOneYear 2024-12-31 14698419 d:ShareCapital 2025-12-31 14698419 d:ShareCapital 2024-12-31 14698419 d:RetainedEarningsAccumulatedLosses 2025-12-31 14698419 d:RetainedEarningsAccumulatedLosses 2024-12-31 14698419 c:OrdinaryShareClass1 2025-01-01 2025-12-31 14698419 c:OrdinaryShareClass1 2025-12-31 14698419 c:OrdinaryShareClass1 2024-12-31 14698419 c:FRS102 2025-01-01 2025-12-31 14698419 c:AuditExempt-NoAccountantsReport 2025-01-01 2025-12-31 14698419 c:FullAccounts 2025-01-01 2025-12-31 14698419 c:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 14698419 d:WithinOneYear 2025-12-31 14698419 d:WithinOneYear 2024-12-31 14698419 d:BetweenOneFiveYears 2025-12-31 14698419 d:BetweenOneFiveYears 2024-12-31 14698419 e:PoundSterling 2025-01-01 2025-12-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 14698419









NEXT GEN DIAGNOSTICS UK LTD







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 DECEMBER 2025

 
NEXT GEN DIAGNOSTICS UK LTD
REGISTERED NUMBER: 14698419

BALANCE SHEET
AS AT 31 DECEMBER 2025

2025
2024
Note
£
£

  

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 4 
37,384
27,392

Cash at bank and in hand
  
47,872
5,467

  
85,256
32,859

Creditors: amounts falling due within one year
 5 
(3,971)
(3,510)

NET CURRENT ASSETS
  
 
 
81,285
 
 
29,349

TOTAL ASSETS LESS CURRENT LIABILITIES
  
81,285
29,349

Creditors: amounts falling due after more than one year
 6 
(863,220)
(338,848)

NET LIABILITIES
  
(781,935)
(309,499)


CAPITAL AND RESERVES
  

Called up share capital 
 7 
1,000
1,000

Profit and loss account
  
(782,935)
(310,499)

  
(781,935)
(309,499)


Page 1

 
NEXT GEN DIAGNOSTICS UK LTD
REGISTERED NUMBER: 14698419
    
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2025

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the profit and loss account in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




E Bragin
Director

Date: 16 September 2026

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
NEXT GEN DIAGNOSTICS UK LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

1.


GENERAL INFORMATION

Next Gen Diagnostics UK Ltd is a private company limited by shares and incorporated in England and Wales. Its registered office is C/O Cms Cameron Mckenna Olswang LLP, Cannon Place, 78 Cannon Street, London, EC4N 6AF.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

GOING CONCERN

The Company incurred a loss for the financial year and had net liabilities of £781,935 as at 31 December 2025 (2024 - £309,499). The financial statements are prepared on the going concern basis on the assumption that the Company will continue to receive financial support from its parent company to provide funds to enable it to meet its liabilities as they fall due.

 
2.3

OPERATING LEASES: THE COMPANY AS LESSEE

Rentals paid under operating leases are charged to profit or loss on a straight-line basis over the lease term.

 
2.4

PENSIONS

DEFINED CONTRIBUTION PENSION PLAN

The Company operates a defined contribution plan for its employees. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. Once the contributions have been paid the Company has no further payment obligations.

The contributions are recognised as an expense in profit or loss when they fall due. Amounts not paid are shown in accruals as a liability in the Balance Sheet. The assets of the plan are held separately from the Company in independently administered funds.

Page 3

 
NEXT GEN DIAGNOSTICS UK LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

2.ACCOUNTING POLICIES (CONTINUED)

 
2.5

TAXATION

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
∙The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
∙Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.6

DEBTORS

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.7

CASH AND CASH EQUIVALENTS

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.8

CREDITORS

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.


3.


EMPLOYEES

The average monthly number of employees, including directors, during the year was 4 (2024 - 2).




Page 4

 
NEXT GEN DIAGNOSTICS UK LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

4.


DEBTORS

2025
2024
£
£


Other debtors
22,402
22,402

Prepayments and accrued income
14,982
4,990

37,384
27,392



5.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2025
2024
£
£

Accruals and deferred income
3,971
3,510



6.


CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2025
2024
£
£

Amounts owed to group undertakings
863,220
338,848



7.


SHARE CAPITAL

2025
2024
£
£
ALLOTTED, CALLED UP AND FULLY PAID



1,000 (2024 - 1,000) Ordinary shares of £1.00 each
1,000
1,000


Page 5

 
NEXT GEN DIAGNOSTICS UK LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025

8.


COMMITMENTS UNDER OPERATING LEASES

At 31 December 2025 the Company had future minimum lease payments due under non-cancellable operating leases for each of the following periods:

2025
2024
£
£


Not later than 1 year
37,336
37,336

Later than 1 year and not later than 5 years
37,336
74,672

74,672
112,008

The parent company, Next Gen Diagnostics LLC, is guarantor of the full lease commitment.

 
Page 6